Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population

JAMA - Journal of the American Medical Association

Volumn 312, Issue 18, 2014, Pages 1927-1928

  Van Der Meer, Adriaan J ^a   Wedemeyer, Heiner ^b   Feld, Jordan J ^c   Dufour, Jean François ^d   Zeuzem, Stefan ^e   Hansen, Bettina E ^a   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON;

ADULT; ANTIVIRAL THERAPY; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; OVERALL SURVIVAL; POPULATION RESEARCH; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE; CASE CONTROL STUDY; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIFE EXPECTANCY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 84918817051     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.12627     Document Type: Article

References (6)

1. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160(5):293-300.
2. Lee MH, Yang HI, Lu SN, et al; R.E.V.E.A.L.-HCV Study Group. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012; 206(4):469-477.
3. van der Meer AJ, Veldt BJ, Feld JJ, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308(24):2584-2593.
4. van der Meer AJ, Wedemeyer H, Feld JJ, et al. Is there sufficient evidence to recommend antiviral therapy in hepatitis C? J Hepatol. 2014;60(1):191-196.
5. Hsu YC, Lin JT, Ho HJ, et al. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology. 2014;59(4):1293-1302.
6. Akamatsu M, Yoshida H, Shiina S, et al. Sustained viral response prolonged survival of patients with C-viral hepatocellular carcinoma. Liver Int. 2006;26(5): 536-542.